minimally defective, and more substantially altered viral forms and that complementation among them is readily attainable. In addition, the limited degree of genotypic heterogeneity observed among HIV-lyu and other brain-derived viruses and their preferential tropism for monocyte-macrophages suggest that viral replication within the central nervous system may differ from that within the peripheral lymphoid compartment in significant and clinically important ways. The availability of genetically and biologically well characterized HIV-1 clones from uncultured human tissue should facilitate future studies of virus-cell interactions relevant to viral pathogenesis and drug and vaccine development.
Although human immunodeficiency virus type 1 (HIV-1) is known to be the cause of AIDS, the pathogenic mechanisms responsible for its many disease manifestations remain enigmatic. Among the most important unanswered questions relating to AIDS pathogenesis are the basic virologic and cellular processes underlying both CD4+ lymphocyte depletion and the neurologic dysfunction associated with AIDS dementia complex (ADC). Many different possible explanations have been considered for these pathologic outcomes, including both virally mediated and immunopathologically mediated processes (3, 24, 35, 43, 62, 67, 93, 98) . There is increasing evidence that virus replication and the accumulated tissue burden of virus and viral products play an important and direct role in AIDS pathogenesis. For example, there is a direct relationship between high-level viral replication and rapid decline in CD4+ cells in primary HIV-1 infection (15, 18, 101) and between increasing virus burden and accelerated disease progression in late infection (16, 42, 65, 84, 89) . Similarly, a positive correlation exists between the level of HIV-1 expression in the central nervous system 6588 LI ET AL. provirus) have been reported to comprise as much as 10 to 15% of the virus population in vivo, thus implying that most viral sequences are multiply defective (64) . While other studies (6, 53) suggest that the prevalence of defective forms may be less than this extreme number, it is conceivable that defective viral genomes play an important role in modulating the biologic expression of HIV-1 infection. In related AIDS animal model systems, replication-defective forms of feline leukemia virus (75) and murine leukemia virus (5, 13) play a central role in disease pathogenesis.
Virus replication and burden, genotypic variation, and biologic diversity are thus all important determinants of AIDS pathogenesis which are inseparably linked to the genetic composition of HIV-1 in vivo. Analysis of the genetic and biologic characteristics of HIV-1 from infected individuals at various stages of disease and with different clinical presentations has therefore been a focus of scientific attention leading to the identification, for example, of macrophage-and T-cell-tropic virus strains (14, 32, 33, 45, 52, 60, 91) , syncytium-inducing and non-syncytium-inducing virus strains (25, 92, 103, 104) , and the quasi-species nature of viral infection in general (34, 37, 64, 85, 94, 95, 112) . However, as a consequence of the generally low abundance of viral DNA in patient tissues (94, 95) , the molecular analysis of HIV-1 in vivo has, by necessity, been limited to the study of culture-amplified virus isolates, proviral DNA clones derived from them, and polymerase chain reaction (PCR)-amplified subgenomic viral fragments. These approaches can be problematic since even brief periods of culture can lead to selection of virus subpopulations that do not accurately represent the predominant species in vivo (53, 64) . In the extreme case, isolation and propagation of virus in immortalized T-cell lines has yielded virus strains with biologic properties (e.g., stability of the gpl20/41 envelope complex and its affinity for CD4) which differ significantly from those of primary isolates (17, 68) . Similarly, PCRamplified subgenomic fragments must, by definition, be studied outside the context of the individual interactive viral unit from which they were derived (53) .
On the basis of these considerations, we sought to clone full-length viral DNA genomes directly from primary human tissue. From our earlier studies of HIV-1 DNA sequences in uncultured human tissues (94, 95) , we suspected that it might be possible to clone unintegrated circular forms from such material, thereby avoiding any possibility of culture-related selection pressures. Infected brain tissue was chosen as a cloning source because of its relatively high abundance of viral DNA (76, 77, 95) and the possibility that this compartment might harbor viral strains with unique genetic and biologic properties relevant to the pathogenesis of ADC (32, 93, 98) . In a previous report (60), we described the generation of 10 recombinant HIV-1 DNA clones from brain tissue, including four full-length HIV-1 genomes, one chromosomally integrated proviral half-genome, and five incomplete genomes with deletions or rearrangements. In the present study, we analyzed the replicative properties of the four full-length HIV-1 clones and determined the complete nucleotide sequences, genome organization, and biologic properties of two of them. This approach allowed us, for the first time, to examine directly the genomic organization, molecular complexity, and biologic properties of HIV-1 in vivo. (33a) ; and the glioblastoma cell lines D54 (10) and CH235 (9) . PBMCs were prepared as described previously (15, 97) Complementation studies. To explore the possibility of retroviral complementation among the four clones (HIV-'YU-2, HIV-lyu-10, HIV-1YU-21, and HIV-1YU-32), the respective plasmids were mixed together in all possible combinations (5 p.g of each) and transfected into Cos-1 cells by the calcium phosphate precipitation method (4). Twentyfour hours after transfection, S x 106 PHA-stimulated normal human PBMCs were added to the Cos-1 monolayer and cocultivated for an additional 48 h. Nonadherent PBMCs were then transferred from six-well plates to T25 flasks, cocultivated with additional PHA-stimulated PBMCs, and monitored for RT activity. After 7 to 10 days, the culture supernatants were equilibrated for RT levels, clarified by low-speed centrifugation (600 x g for 10 min), filtered (1.2-,um-pore-size filters), and transmitted cell free to uninfected PHA-stimulated PBMCs. The medium was changed weekly, new PBMCs were added, and the culture supernatants were checked for p24 antigen and RT activity. Viral replication, transmission, and complementation experiments were repeated three to five times, with similar results; representative data are shown in the figures.
MATERIALS AND METHODS
Nucleotide sequence accession numbers. The sequence data reported have been assigned GenBank accession numbers M93258 (HIV-1YU-2) and M93259 (HIV-lyu-10).
RESULTS
Nucleotide sequence and genome organization of HIV-1yu-2 and HIV-1yu lo. The complete nucleotide sequences of HIVlYU-2 and HIV-lyu-10 were determined (Fig. 1) . The viral genomes extended 9,174 and 9,176 nucleotides (nt), respectively, from the beginning of the long terminal repeat (LTR) R sequence (corresponding to the mRNA start site) to the terminus of R in the 3' LTR (the site of polyadenylation). The potential ORFs deduced from the two sequences ( (48), and the cis-acting tat-responsive element (83) , were conserved. Similarly, the primer binding site, polyadenylation signal (AATAA), central and 3' polypurine tracts, consensus splice donor and acceptor sites, and consensus RNA packaging signal were present (12, 57, 70, 106) .
Coding sequences corresponding to p17, p24, p9, and p7 in gag and plO (protease), p66 (RT), and p32 (integrase) in pol were similar in length to sequences in the gag and pol genes of previously characterized HIV-1 proviruses (63, 106, 108) . The myristylation site for p17 gag (amino-terminal glycine) and two copies of the zinc finger motif (Cys-X2-Cys-X4-His-X4-His-X4-Cys) (7, 8, 63, 108) in the p9 nucleocapsid protein were also present. The p17 matrix protein and the p24 major capsid protein each contained potential serine-linked phosphorylation sites (Arg-X-Ser) (63, 108) , as shown in Fig. 1 .
HIV-1YU2 and HIV-lyuo10 differed importantly in the pol gene. The latter sequence contained a one base pair deletion at position 2440, resulting in premature termination of the ORF at position 2502, 714 amino acids short of the normal terminus of the polyprotein precursor. In the RT gene of HIV-1YU-2 (and in the corresponding region of HIV-lyu-10), the codons at amino acid positions 41 (Met), 67 (Asp), 70 (Lys), 103 (Lys), 181 (Tyr), 215 (Thr), and 219 (Lys) (nt 2219, 2297, 2306, 2405, 2639, 2741, and 2753 in Fig. 1 ) corresponded to wild-type sequences found in viruses from drugnaive patients which are sensitive to AZT (11, 49, 54, 55) and the non-nucleoside RT inhibitors BI-RG-587, R82913, and L697,661 (22) .
The tat genes of HIV-1YU 2 and HIV-lyu-10 comprised two exons, one 216 nt in length preceding the env gene and the other 87 nt long overlapping env. The second tat exon, 29 codons in length, was similar to the exons of a number of HIV-1 isolates but longer than others (70, 106 TyrHisThrGlnGlyTyrPheProAspTrpGlnAsnTyrThrProGly ... GlyThrArgTrpProLeuThrPheGlyTrpCysPheLysLeuValProValGluProGluLysIleGluGluAlaAsnAlaGlyGluAs The length and hydrophobicity profile of the env ORF (2529 nt; 843 amino acids) and the number and position of its cysteine residues and potential N-linked glycosylation sites (21 and 27, respectively), were very similar between HIVlYUT2 and HIV-lyuo10 and previously characterized HIV-1 strains (70). In hypervariable region V3 (corresponding to amino acid positions 292 to 326 from the env methionine initiation codon; Fig. 1 indicate a specific clustering with these viruses (Fig. 5 ).
DISCUSSION
The results of this study provide a unique view of the genetic and biologic characteristics of HIV-1 in vivo and the natural history of HIV-1 infection. The viral clones analyzed were obtained from uncultured brain tissue of a man who died with ADC. Thus, unlike all other full-length HIV-1 clones, they were not subjected to any form of tissue cuIture selection, reflecting instead only the consequences of viral replication, persistence, and natural selection in this individual and those infected before him.
Previous studies of the genomic organization of highly passaged prototype HIV-1 strains (HIV-1IIIB, HIV-lAv, and HIV-lARV-2) identified a complex array of genes that is now recognized to include 5'-LTR-gag-pol-vif-vpr-tat-revvpu-env-nef-LTR-3' (69, 82, 88, 110) . Subsequent studies confirmed this general organization but also revealed a high frequency of base substitutions, deletions, and insertions which often led to obvious disruptions of certain of these ORFs (34, 37, 64, 100) . Deletion or truncation of the major structural genes gag,pol, and env and the nuclear regulatory genes tat and rev resulted in replication-defective virus, and these genes were therefore described as essential (20) . Disruption of the vif, vpr, vpu, or nef ORF, on the other hand, still allowed viral replication to proceed in vitro, although such viruses were frequently altered phenotypically. These genes, along with the vpx gene of HIV-2, were therefore described as nonessential accessory (or auxiliary) genes (20) . However, the striking evolutionary conservation of these accessory genes, and the recent demonstration of the importance of nef to simian immunodeficiency virus pathogenesis in rhesus macaques (50) (60) . The number and position of cysteine residues and potential N-linked glycosylation sites were conserved in comparison with prototype HIV-1 isolates, as were the amino acids known to be involved in CD4 receptor binding (74, 105) . Interestingly, while the overall env DNA sequence of HIV-1YU2 was approximately equidistantly related to T-cell-tropic and monocyte-tropic North American/European isolates (Fig. 5) , the amino acid sequence of the V3 region was specifically similar to those of three other wellstudied monocyte-tropic viruses, HIV-lBAJ (33) , HIV-lJRFL (52) , and HIV-1ADA (111) The availability of full-length sequences of HIV-YU-2 and HIV-lyu-10, as well as previously reported partial envelope sequences from 6 additional lambda phage-derived and 12 PCR-derived clones from the same subject's brain tissue (60) , allowed us to analyze the genetic composition of the HIV-1 quasi-species in vivo in ways not previously possible. While all 20 clones were derived from the same tissue, the 8 lambda clones represented unintegrated HIV-1 DNA intermediates whereas the PCR clones represented both unintegrated and integrated viral forms. The HIV-1YU2 and HIVlyu-10 sequences differed from each other by surprisingly few nucleotide changes, 24 of 9,085 (0.26%). This limited degree of variation was clearly representative of the overall population of viral sequences within the brain compartment of this individual, since the 6 other lambda phage-derived clones and 11 of the 12 PCR-derived clones differed to a similar degree, 0 to 1.2%. These data thus provide rather striking evidence that the extent of HIV-1 variability in brain tissue is considerably less than that in the peripheral lymphoid compartment, where the range in HIV-1 variability within individual patients has generally been reported to be between 1.0 and 9.2% (6, 53) . The degree of variation among brain-derived HIV-1 sequences that we observed is in the same range as that described in other studies of intrapatient variation of brain-derived HIV-1 (23, 76; unpublished data The availability of four full-length HIV-1 genomes also enabled us to examine the phenomenon of G-to-A hypermutation in vivo (34, 107) . Since all four full-length clones that we studied were either replication competent or only minimally defective, they were not expected to have excessive G-to-A changes because such changes invariably lead to multiple premature termination codons as a result of alterations in tryptophan codons (i.e., TGG to TGA, TAG, or TAA). In the HIV-1YU-2 and HIV-lyu-10 sequences, there was suggestive evidence for preferential G-to-A substitution but not hypermutation (i.e., 15 of 24 nucleotide differences [60%] involved G-to-A substitutions, whereas the expected frequency of such changes in a genome of this base composition would be approximately 20%). Eight of these fifteen changes occurred in a GpA motif which has been suggested to be a preferential site for G-to-A hypermutation on the basis of dislocation mutagenesis (107) . Thus, our analysis of this individual's brain tissue revealed a trend toward preferential G-to-A substitution between two full-length clones and extreme G-to-A hypermutation in 1 of 12 PCR-derived clones (60) . The generality of G-to-A hypermutation in vivo and its biologic significance remain unknown.
A striking finding of our analyses was that any combination of the defective clones HIV-lyu-10, HIV-1YU-21, and HIV-1YU-32 resulted in prompt complementation and wildtype levels of viral replication, as measured by p24 antigen and RT production, virus-induced syncytium induction, and production of virus that could be passaged cell free onto normal donor PBMCs. The fact that HIV-lyu110 could be complemented by either HIV-1YU 21 or HIV-1YU 32 suggests that these latter viruses have an intact pol gene to complement the defective pol gene in HIV-lyu-10 ( Fig. 1 and 2 ).
Similarly, HIV-1YU-21 and HIV-1YU-32 are likely to be defective in different genes, since they can complement each other. However, it cannot be determined from our experiments whether the observed complementation was due to homologous recombination between heterotypic viral genomes or to phenotypic mixing and continued transmission of defective genomes. Hu and Temin (44) have recently shown that as many as 30 to 40% of dimeric viral genomes recombine during a single cycle of infection, making this a distinct possibility in our system. Complementation by defective HIV-1 genomes has also been reported by Inoue et al. (46) , although their results were based on an analysis of viral clones derived from a heavily passaged laboratoryadapted strain of HIV-lIIIB. The biologic significance of viral defectiveness and complementation in HIV-1 pathogenesis is currently unknown, and even the extent of defectiveness of HIV-1 in vivo is uncertain. Meyerhans et al. reported (64) that 10 to 15% of tat genes (which represent less than 3% of the viral genome) were defective, implying that virtually all genomes in vivo must be multiply defective. Conversely, Balfe et al. (6) and Kusumi et al. (53) have independently estimated that HIV-1 genomes in vivo contain, on average, one or fewer obviously lethal mutations. Our data for HIV-1YU2, HIV-lyu-10, HIV-lYUT21, and HIV-1YU-32 are more consistent with the latter estimates. These different results may reflect the limited numbers of subjects analyzed, differences in the stages of their clinical illnesses, and/or the different tissues analyzed. It has been suggested that because the copy number of HIV-1 proviruses in infected PBMCs is low (approximately one), functional complementation of even minimally defective genomes would not generally be possible and therefore complementation is unlikely to be important in viral pathogenesis (6) . However, other considerations suggest a different interpretation. First, viral DNA burden and expression are higher, transmission by cell-cell contact is more likely, and the opportunity for complementation is therefore greater in lymphoid organs and brain tissue than in circulating PBMCs (76-78, 94, 95) . Second, cells that harbor HIV-1 in vivo have been shown to maintain their expression of CD4 (90) , and consequently there is the opportunity for multiple infection events at a single-cell level. Thus, we believe that the question of the relative importance of defective HIV-1 genomes in viral pathogenesis remains open and worthy of consideration.
In conclusion, the results of this study provide new insight into the genetic and biologic characteristics of the HIV-1 quasi-species that evolves and persists within the CNS compartment and provide new viral reagents for analyzing gene structure-function relationships. The HIV-lYU2 clone, in particular, with its monocyte-tropic phenotype, nearconsensus V3 envelope sequence, and wild-type polymerase sequence with regard to AZT and non-nucleoside analog drug sensitivity, may be particularly useful for studies related to viral pathogenesis and drug and vaccine development.
